"Bone Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer located in bone tissue or specific BONES.
| Descriptor ID |
D001859
|
| MeSH Number(s) |
C04.588.149 C05.116.231
|
| Concept/Terms |
Bone Neoplasms- Bone Neoplasms
- Bone Neoplasm
- Neoplasm, Bone
- Neoplasms, Bone
|
Below are MeSH descriptors whose meaning is more general than "Bone Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Bone Neoplasms".
This graph shows the total number of publications written about "Bone Neoplasms" by people in this website by year, and whether "Bone Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 0 | 3 |
| 1996 | 8 | 1 | 9 |
| 1997 | 2 | 1 | 3 |
| 1998 | 4 | 3 | 7 |
| 1999 | 2 | 0 | 2 |
| 2000 | 3 | 2 | 5 |
| 2001 | 3 | 2 | 5 |
| 2002 | 1 | 2 | 3 |
| 2003 | 3 | 2 | 5 |
| 2004 | 2 | 1 | 3 |
| 2005 | 5 | 1 | 6 |
| 2006 | 3 | 2 | 5 |
| 2007 | 4 | 1 | 5 |
| 2008 | 6 | 2 | 8 |
| 2009 | 6 | 1 | 7 |
| 2010 | 8 | 3 | 11 |
| 2011 | 9 | 2 | 11 |
| 2012 | 7 | 1 | 8 |
| 2013 | 8 | 0 | 8 |
| 2014 | 13 | 2 | 15 |
| 2015 | 17 | 1 | 18 |
| 2016 | 10 | 0 | 10 |
| 2017 | 14 | 2 | 16 |
| 2018 | 9 | 1 | 10 |
| 2019 | 12 | 2 | 14 |
| 2020 | 8 | 1 | 9 |
| 2021 | 9 | 1 | 10 |
| 2022 | 12 | 0 | 12 |
| 2023 | 10 | 0 | 10 |
| 2024 | 12 | 0 | 12 |
| 2025 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bone Neoplasms" by people in Profiles.
-
Update on Cancer Screening in Children with Syndromes of Bone Lesions, Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome, and Other Rare Syndromes. Clin Cancer Res. 2025 Feb 03; 31(3):457-465.
-
The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma. Nat Commun. 2025 Feb 02; 16(1):1267.
-
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial. JAMA Oncol. 2024 Dec 01; 10(12):1645-1653.
-
Differential bone morphology and hypoxia activity in skeletal metastases of ER+ and ER- breast cancer. Commun Biol. 2024 Nov 21; 7(1):1545.
-
The role of Cabazitaxel in Patients With Castration-Resistant and Osseous Metastases Prostate Cancer. A Hellenic Cooperative Oncology Group Phase II Study: Cabazitaxel in mCRPC patients with osseous metastases. Clin Genitourin Cancer. 2025 Feb; 23(1):102253.
-
Pediatric Ewing Sarcoma Presentation, Treatment, and Outcomes Across Sociodemographic Groups. J Surg Res. 2024 Nov; 303:322-331.
-
Does a Concise Patient-reported Outcome Measure Provide a Valid Measure of Physical Function for Cancer Patients After Lower Extremity Surgery? Clin Orthop Relat Res. 2025 Jan 01; 483(1):62-75.
-
Sympathetic Blockade for Pain Associated With Nonaxial Bone Lesions in Patients With Cancer: An Uncontrolled Cohort. J Natl Compr Canc Netw. 2024 10; 22(8):537-542.
-
Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models. Clin Cancer Res. 2024 Oct 01; 30(19):4434-4449.
-
Antiangiogenic Tyrosine Kinase Inhibitors have Differential Efficacy in Clear Cell Renal Cell Carcinoma in Bone. Cancer Res Commun. 2024 10 01; 4(10):2621-2637.